FDA Investigator Marlene L Davis

Marlene L Davis has inspections in 4 countries as of 07 Nov 2023. Marlene L Davis has collaborated with a combinined 3462 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Canada, Italy, Spain
Alan R Condon, Alexander M Kay, Alia Legaux, Alice C Silva, Althea A Williams, Amanda F Smith, Amanda J White, Amy Kim, Andrew J Barrowcliff, Ann B Okon, Ann Marie Karnick, Anna E Fain, Anthony N Onianwa, Arduino Frankovic, Arthur G Hurst, Barbara D Wright, Benton M Ketron, Bradford L Swanson, Brenda P King, Brian J Ryan, Bruce G Cooper, Bryan Baker, Camilla S Smith, Cara M Minelli, Carley R Anderson, Carolyn J Cook, Catherine M Beer, Charles N Dupont, Christine A Harman, PhD, Christopher J Smith, Christopher S Fields, Claude L Brunson, Connie L Hannon Rabel, Crystal A Branch, Cynthia L Medlin, Cynthia L Rakestraw, Dan G Eisenbrey, Dana M Klimavicz, Daniel L Aisen, Daphne A Videau, Dave M Deroche, David A Carlson, David A Trent Carlson, David J Leray, David R Delucia, Denise L Terzian, Dennis G Kawabata, Dennis R Hudson, Derik V Rose, Diamond M Oden, Dipesh K Shah, Dolores E Price, Donald J Ullstrom, Donald W Jehn, Donna D Gallien, MPH, Eddie J Rigsby, Elizabeth B Griffin, Elizabeth D Connell, Elizabeth H Davis, Elizabeth H Slazak, Elkins, Ellen P Madigan, Eric M Silberhorn, Erica L Nicoll, Erik W Koester, Erin L Nagel, Esther A Ofori, Evelyn Taha, Francis A Guidry, Gail L Katz, George C Amedro, Gerald Mierle, Gina C Collins, Gloria J Baca, MS, Gray, Harlan J Howard, Harry J Brewer, Hilary K Wagner, Hoimay Chan, Holly M Zahner, Hugh M Mcclure, II, Irina Gaberman, Ismael Olvera, IV, Jackson Y See, Jacqueline Mdiaz Albertini, James D Bridges, James W Blakely, James W Whitney, Jeanette L Mcginnis, Jeffrey R Alling, Jennifer A Hart, Jerri E Lothrop, Jessica L Walters Moell, Jin Gao, Joan A Loreng, Joanne M Schlossin, Joel R Merriman, Johannes S Corley, Johnna L Bleem, Jose O Hernandez, Joseph A Famiglietti, Joseph J Vannelli, Joseph Milcetic, Joseph T Frost, Joy P Matthias, Joyce A Williams, Joyce B Watson, Juan Rjimenez Garcia, Juanelma H Palmer, Judy Ellen Ciaraldi, Judy Keihl, Karan L Blum, Karen L Kosar, Katherine L Huebner, Kathryn A Krentz, Kathryn A Nagy, Kellie Leveille, Kenneth G Klobus, Kent A Conforti, Kim M Downing, Kimberley A Ricketts, Kimberly A Dux, Kimberly Y Smithson, Kip J Hanks, Kyle J Spencer, La Tasha M Gunter, Lauren E Blaser, Lauren E Swantko, Laurie A Haxel, Laurie B Frazier, Leena Thomas, Leeterry Moore, Linda M Sacco, Lori A Holmquist, Lori P Peters, LTJG Bradley E Benasutti, LTJG Matthew R Palo, Luis A Carrion, M Aabel I, Marc S Neubauer, Margaret M Sands, Mark W Rivero, Martha A Forsythe, Mary Alice Papdimitriou, Mary M Finn, Mary T Carden, Maryna C Eichelberger, PhD, Matthew C Watson, Matthew D Schnittker, Melissa N Gregorio, Michael A Charles, Michael G Sinkevich, Michael R Dominick, Michael W Burd, Michele M Falchek, Mindy M Chou, Morris Paul, Nancy L Neiger, Nicholas C Mendiola, Nicole A Earnshaw, Patricia A Clark, Paul P Geraci, Randi Lynn Bodoh, Randy D Baxter, Rebecca E Cluster, Regina T Brown, Richard K Glabach, Robert J Veitch, Rory K Geyer, Russ E Davis, Samina S Khan, Sarah Forney, Shannon A Dinardo, Shelley L Waring, Sherry M Nisson, Simone E Pitts, Sony Mathews, State Agency, Stephen J Rabe, Steven J Libal, Susan M Jackson, Susan M Miller, Syeda N Mahazabin, Tammy S Notto, Terrance L Thomas, Terry C Kimball, Thomas L Bellonte, Tiana M Mckinley, Travis M Beard, Travis R Hunt, Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Verdell Nelson, Vivian Garcia, Wendy M Stone, William C Lubas, William F Lagud, Jr, William J Leonard, Young M Yoon, Yvonne M Santiago, Zameer Farouk

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more